BRL-301

BRL-301 CAR-T cells · Bioray Laboratories

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BRL-301, covering 2024-09-27 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases [NA]